[go: up one dir, main page]

MX2014001940A - Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. - Google Patents

Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Info

Publication number
MX2014001940A
MX2014001940A MX2014001940A MX2014001940A MX2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A
Authority
MX
Mexico
Prior art keywords
oral
administration
nasal inhalation
aerosol product
pharmaceutical aerosol
Prior art date
Application number
MX2014001940A
Other languages
English (en)
Inventor
Helgert Müller
Renate Engelstätter
Ulrich Bildmann
Andrea Bauer
Paul Mcglynn
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of MX2014001940A publication Critical patent/MX2014001940A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a un producto farmacéutico de aerosol adecuado para administración por inhalación oral o nasal, y a su uso en el tratamiento de enfermedades respiratorias, en particular en el tratamiento de los niños. La composición de aerosol comprende ciclesonida, etanol y 1,1,1,2-tetrafluoroetano o 1,1,1,2,3,3,3-heptafluoro propano.
MX2014001940A 2011-08-18 2012-08-13 Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. MX2014001940A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161524803P 2011-08-18 2011-08-18
EP11178042 2011-08-19
PCT/EP2012/065812 WO2013024070A1 (en) 2011-08-18 2012-08-13 Pharmaceutical aerosol product for administration by oral or nasal inhalation

Publications (1)

Publication Number Publication Date
MX2014001940A true MX2014001940A (es) 2014-03-27

Family

ID=47714798

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001940A MX2014001940A (es) 2011-08-18 2012-08-13 Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Country Status (6)

Country Link
US (3) US11007150B2 (es)
EP (1) EP2744479A1 (es)
AU (1) AU2012296880A1 (es)
CA (1) CA2844944A1 (es)
MX (1) MX2014001940A (es)
WO (1) WO2013024070A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11007150B2 (en) * 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
IT201600080879A1 (it) * 2016-08-01 2018-02-01 Giorgio Mezzoli Erogatore

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5421482A (en) 1989-02-03 1995-06-06 Senetics, Inc. Indicator device responsive to axial force
US5718355A (en) 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
DE69105212T2 (de) 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
WO1995002651A1 (en) 1993-07-15 1995-01-26 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
US5474758A (en) 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
US5505192A (en) 1993-11-12 1996-04-09 New-Med Corporation Dispenser monitoring system
GB2288259A (en) 1994-03-30 1995-10-11 Norton Healthcare Ltd Inhaler dose counter
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
ES2206572T3 (es) 1995-04-14 2004-05-16 Smithkline Beecham Corporation Inhalador de dosis medida para salmeterol.
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US5871007A (en) 1997-06-09 1999-02-16 Chase Marketing International L.L.C. Throat spray counting mechanism
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
FR2842905B1 (fr) 2002-07-29 2005-05-13 Valois Sa Indicateur de doses pour dispositif de distribution de produit fluide
US20040023935A1 (en) 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
FR2850192B1 (fr) 2003-01-20 2005-05-06 Tebro Indicateur de doses pour dispositif de distribution de produit fluide.
EP1635845A1 (en) 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
FR2857770B1 (fr) 2003-07-18 2005-10-21 Valois Sas Indicateur de doses ameliore pour dispositif de distribution de produit fluide.
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
GB0328502D0 (en) 2003-12-10 2004-01-14 3M Innovative Properties Co Metered dose dispensers and assemblies therefor
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (en) 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1991295B1 (en) 2006-03-03 2016-02-10 3M Innovative Properties Company Apparatus for metered dosed dispensing
US11007150B2 (en) * 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Also Published As

Publication number Publication date
EP2744479A1 (en) 2014-06-25
US20240226006A1 (en) 2024-07-11
US20140170081A1 (en) 2014-06-19
CA2844944A1 (en) 2013-02-21
US11007150B2 (en) 2021-05-18
WO2013024070A1 (en) 2013-02-21
US11992556B2 (en) 2024-05-28
US20210267888A1 (en) 2021-09-02
AU2012296880A1 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
EP2749277A3 (en) Combination of glycopyrronium and vilanterol
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
WO2014064410A8 (en) Pharmaceutical composition
IL216467B (en) Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate or formoterol and their use in treatment of pulmonary diseases
SG11201804449WA (en) 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
HK1146485A1 (es)
PH12016500433B1 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
MY175804A (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
WO2012040228A3 (en) Aerosol composition for administering drugs
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
WO2014007772A3 (en) Inhalation compositions comprising glucose anhydrous
WO2014007781A3 (en) Inhalation compositions
CY1117596T1 (el) Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.
WO2013153349A3 (en) Pharmaceutical composition comprising arformoterol and fluticasone furoate
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine